Nissan Medical Industries Statistics

Total Valuation

Nissan Medical Industries has a market cap or net worth of ILS 146.52 million. The enterprise value is 449.08 million.

Market Cap	146.52M
Enterprise Value	449.08M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Nissan Medical Industries has 9.08 million shares outstanding. The number of shares has increased by 3.37% in one year.

Current Share Class	n/a
Shares Outstanding	9.08M
Shares Change (YoY)	+3.37%
Shares Change (QoQ)	+1.84%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	2.87%
Float	n/a

Valuation Ratios

The trailing PE ratio is 7.58.

PE Ratio	7.58
Forward PE	n/a
PS Ratio	0.20
PB Ratio	0.61
P/TBV Ratio	n/a
P/FCF Ratio	2.72
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.46, with an EV/FCF ratio of 8.33.

EV / Earnings	23.09
EV / Sales	0.62
EV / EBITDA	4.46
EV / EBIT	6.37
EV / FCF	8.33

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.49.

Current Ratio	1.17
Quick Ratio	0.52
Debt / Equity	0.49
Debt / EBITDA	1.80
Debt / FCF	3.41
Interest Coverage	3.44

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.91%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	6.14%
Return on Capital (ROIC)	7.91%
Revenue Per Employee	1.85M
Profits Per Employee	49,228
Employee Count	395
Asset Turnover	0.99
Inventory Turnover	4.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.06% in the last 52 weeks. The beta is -0.23, so Nissan Medical Industries's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	+65.06%
50-Day Moving Average	1,443.12
200-Day Moving Average	1,375.24
Relative Strength Index (RSI)	86.02
Average Volume (20 Days)	2,588

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nissan Medical Industries had revenue of ILS 729.00 million and earned 19.45 million in profits. Earnings per share was 2.13.

Revenue	729.00M
Gross Profit	146.11M
Operating Income	72.15M
Pretax Income	49.27M
Net Income	19.45M
EBITDA	96.70M
EBIT	72.15M
Earnings Per Share (EPS)	2.13

Full Income Statement

Balance Sheet

The company has 11.41 million in cash and 184.05 million in debt, giving a net cash position of -172.63 million or -19.01 per share.

Cash & Cash Equivalents	11.41M
Total Debt	184.05M
Net Cash	-172.63M
Net Cash Per Share	-19.01
Equity (Book Value)	377.28M
Book Value Per Share	26.43
Working Capital	39.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.36 million and capital expenditures -7.43 million, giving a free cash flow of 53.92 million.

Operating Cash Flow	61.36M
Capital Expenditures	-7.43M
Free Cash Flow	53.92M
FCF Per Share	5.94

Full Cash Flow Statement

Margins

Gross margin is 20.04%, with operating and profit margins of 9.90% and 2.67%.

Gross Margin	20.04%
Operating Margin	9.90%
Pretax Margin	6.76%
Profit Margin	2.67%
EBITDA Margin	13.26%
EBIT Margin	9.90%
FCF Margin	7.40%

Dividends & Yields

Nissan Medical Industries does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.37%
Shareholder Yield	-3.37%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nissan Medical Industries has an Altman Z-Score of 1.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.98
Piotroski F-Score	n/a